Frank A.J.A. Bodewes

Author

University Medical Center Groningen ORCID

Also Known As

Bodewes, F., Bodewes, FAJA, C. Annema, Erik A.M. Verschuuren, F. A. J. A. Bodewes, F. Bodewes, F.A. Bodewes, F.A.J.A. Bodewes, FAJA Bodewes, Frank A J A Bodewes

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Groningen University of Groningen University Medical Center Utrecht Erasmus MC Assistance Publique – Hôpitaux de Paris

About

Frank A.J.A. Bodewes is an author at University Medical Center Groningen specializing in medicine, pathology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	276
2	Health Sciences	2	2	83
3	Public Health	1	1	24
4	Biochemistry	1	1	23
5	Cell Biology	1	1	19

Frank A.J.A. Bodewes

Publications

904

Citations

H-Index

Page 1

	Year	Citations
Rationale and design of TransplantLines: a prospective cohort study and biobank of solid organ transplant recipients Michele F. Eisenga, António W. Gomes‐Neto, Marco van Londen, BMJ Open	2018	127
Cystic Fibrosis–related Liver Disease Dominique Debray, Michael R. Narkewicz, Frank A.J.A. Bodewes, Journal of Pediatric Gastroenterology and Nutrition	2017	106
Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor Drucy Borowitz, Barry Lubarsky, Michael Wilschanski, Digestive Diseases and Sciences NutritionCystic Fibrosis PatientsInherited Metabolic DiseaseClinical NutritionNutritional Status Improved	2015	92
Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct disease Monique M.A. Verstegen, Floris J.M. Roos, Ksenia Burka, Scientific Reports	2020	85
Pediatric Achalasia in the Netherlands: Incidence, Clinical Course, and Quality of Life Marije Smits, Marinde van Lennep, Remy Vrijlandt, The Journal of Pediatrics Clinical CoursePediatric EpidemiologyPediatricsPediatric AchalasiaPediatric Surgery	2015	68
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations Zachary M. Sellers, David N. Assis, Shruti Paranjape, Hepatology GastroenterologyPathologyDiagnosisCf FoundationCirrhosis	2023	64
Treatment of Infants and Toddlers With Cystic Fibrosis–related Pancreatic Insufficiency and Fat Malabsorption With Pancrelipase MT Els Van de Vijver, Kristine Desager, Andrew E. Mulberg, Journal of Pediatric Gastroenterology and Nutrition	2011	53
Increase of Serum γ‐Glutamyltransferase Associated With Development of Cirrhotic Cystic Fibrosis Liver Disease Frank A.J.A. Bodewes, Hubert P. J. van der Doef, Roderick H.J. Houwen, Journal of Pediatric Gastroenterology and Nutrition	2015	42
IVACAFTOR restores FGF19 regulated bile acid homeostasis in cystic fibrosis patients with an S1251N or a G551D gating mutation Ivo P. van de Peppel, Marcela Doktorova, Gitte Berkers, Journal of Cystic Fibrosis Bile Acid HomeostasisTranslational MedicineG551d Gating MutationCystic Fibrosis PatientsImmunology	2018	33
Time‐to‐reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease Sjoukje‐Marije Haisma, Henkjan J. Verkade, René Scheenstra, Journal of Pediatric Gastroenterology and Nutrition	2019	29

Page 1